Health · 1 views
EVAOLD trial provides guidance on treating older patients after a heart attack
A routine invasive approach should not be replaced with a more selective approach in older patients with the most common type of heart attack.
AI Summary
The EVAOLD trial was presented in a Hot Line session at the ESC Congress 2026. The study examined treatment strategies for older patients who suffer a non‑ST‑segment‑elevation myocardial infarction (NSTEMI), the most common type of heart attack. Its main finding was that a routine invasive approach should not be replaced with a more selective strategy in this population. The trial suggests that maintaining the standard invasive protocol remains appropriate for older NSTEMI patients.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meetingContinue reading
- Almost 75% of A&E staff in UK face violence or aggression daily or weeklyContinue reading
- Laughter therapy can help people with COPD breathe more easilyContinue reading
- Brain signaling mechanism may explain clozapine weight gainContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow